American pharmacist companies will fund Czech research lead by Antonin Holy who developed a cure for patients with AIDS.
Gilead company will give 1,1 millions dollars every year to science institute, where Holy works. 200 000 dollars from this amount is specially for Holy’s research. His last medicine is called Viread, before that he developed Vistide and also cure for chronic Hepatitis B type.
Still there is a small funding from Czech state to science, but some money comes from grants and benefits. Last year it was 166 millions crowns.
The average cost of developing new medicament is about a half milliards dollars.